Search by Drug Name or NDC
NDC 72789-0174-01 Lithium Carbonate 300 mg/1 Details
Lithium Carbonate 300 mg/1
Lithium Carbonate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.
MedlinePlus Drug Summary
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
Related Packages: 72789-0174-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lithium
Product Information
NDC | 72789-0174 |
---|---|
Product ID | 72789-174_f49a9e84-4baa-068e-e053-2a95a90a6e4d |
Associated GPIs | 59500010100305 |
GCN Sequence Number | 004003 |
GCN Sequence Number Description | lithium carbonate TABLET 300 MG ORAL |
HIC3 | H2M |
HIC3 Description | BIPOLAR DISORDER DRUGS |
GCN | 15721 |
HICL Sequence Number | 001669 |
HICL Sequence Number Description | LITHIUM CARBONATE |
Brand/Generic | Generic |
Proprietary Name | Lithium Carbonate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Lithium Carbonate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 300 |
Active Ingredient Units | mg/1 |
Substance Name | LITHIUM CARBONATE |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Pharmaceutical Class | Mood Stabilizer [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA018558 |
Listing Certified Through | 2024-12-31 |
Package
NDC 72789-0174-01 (72789017401)
NDC Package Code | 72789-174-01 |
---|---|
Billing NDC | 72789017401 |
Package | 100 TABLET in 1 BOTTLE, PLASTIC (72789-174-01) |
Marketing Start Date | 2021-03-09 |
NDC Exclude Flag | N |
Pricing Information | N/A |